Gastric cancer is one of the most common malignant tumors in the digestive system. Surgery
is currently considered to be the only radical treatment. As surgical techniques improve and …

Chemotherapy and targeted therapy are the major treatments for gastric cancer (GC), but
drug resistance limits its effectiveness. Here, we profile the proteome of 206 tumor tissues …

Background It is inconclusive whether R1 margin determined by postoperative pathological
examination indicates worse long-term survival in gastric cancer (GC) patients after curative …

Gastric cancer (stomach cancer) is the fifth most common malignancy and the third leading
cause of cancer-associated mortality worldwide. Identifying gastric cancer patients at an …

Purpose: Laparoscopic total gastrectomy for advanced proximal gastric carcinoma is a
complex and challenging procedure, limited to a few expert centers. This study analyzed the …

The optimal management of patients with resection line involvement after endoscopic or
surgical treatment for gastric cancer is debated. In contrast to previous reports, we examined …

Background: Gastric cancer (GC) is among the most prevalent cancers in both genders, and
the survival rate constitutes a measure to evaluate the diagnosis and treatment of GC …

The purpose of this study was to evaluate the long-term outcomes of laparoscopic
gastrectomy for patients with locally advanced gastric carcinoma. Of the 113 patients with …

Previous case-control studies on the association of the angiotensin-converting enzyme
(ACE) gene insertion/deletion (I/D) polymorphism with gastric cancer were controversial. A …

Background: Gastric cancer is the fifth most frequently diagnosed malignancy worldwide and
has a high mortality rate because it is often at an advanced stage at the time of diagnosis …